To understand the underlying mechanism of how linc‐ROR acts as an oncogene and decreases the sensitivity of breast cancer cells to rapamycin, the whole transcriptome sequencing was conducted on LV‐linc‐ROR and LV‐NC. This evidence concerns the gene LINC-ROR and breast carcinoma.